Literature DB >> 1591873

Pathogenic factors in inflammatory bowel disease. 2. Crohn's disease.

P Pavli1, P R Gibson.   

Abstract

Clues from patient and experimental animal studies suggest that events occurring early in the pathogenesis of Crohn's disease are related to an inability of the immune system to eradicate one or a number of luminal antigens resulting in persistent T cell and macrophage activation. Whether the primary abnormality rests with the nature of the luminal antigen, disturbances of antigen uptake by the mucosa, antigen handling by macrophages, or macrophage-T cell interactions remains unresolved. Given the heterogeneity of clinical presentations and experimental data, Crohn's disease may be a group of disorders associated with a number of primary defects.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1591873     DOI: 10.1159/000171346

Source DB:  PubMed          Journal:  Dig Dis        ISSN: 0257-2753            Impact factor:   2.404


  5 in total

1.  Impaired mitogenic response of peripheral blood T cells in ulcerative colitis is not due to apoptosis.

Authors:  M A Pérez-Machado; L M Espinosa; E J de la Madrigal; L Abreu; G M Lorente; M Alvarez-Mon
Journal:  Dig Dis Sci       Date:  1999-12       Impact factor: 3.199

Review 2.  Reinforcing the mucus: a new therapeutic approach for ulcerative colitis?

Authors:  P R Gibson; J G Muir
Journal:  Gut       Date:  2005-07       Impact factor: 23.059

Review 3.  Intestinal macrophages: differentiation and involvement in intestinal immunopathologies.

Authors:  Benjamin Weber; Leslie Saurer; Christoph Mueller
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

4.  Molecular evidence for two forms of Crohn disease.

Authors:  E C Gilberts; A J Greenstein; P Katsel; N Harpaz; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

5.  On the etiology of Crohn disease.

Authors:  D Mishina; P Katsel; S T Brown; E C Gilberts; R J Greenstein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.